Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Juris

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cellular Microbiology|April 16, 2002
Yersinia effectors target mammalian signalling pathwaysStephen J Juris, Feng Shao, Jack E Dixon
The Journal of General Physiology|February 11, 2009
Evidence for a proton-protein symport mechanism in the anthrax toxin channelDaniel Basilio, Stephen J Juris, R John Collier, et al.
FEBS Letters|December 21, 2005
Identification of otubain 1 as a novel substrate for the Yersinia protein kinase using chemical genetics and mass spectrometryStephen J Juris, Kavita Shah, Kevan Shokat, et al.
Infection and Immunity|July 20, 2007
Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxinStephen J Juris, Roman A Melnyk, Robert E Bolcome, et al.
The Journal of Biological Chemistry|March 27, 2004
Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigenDarran J Wigelsworth, Bryan A Krantz, Kenneth A Christensen, et al.
Biochimie|December 31, 2016
Dichotomous effects of isomeric secondary amines containing an aromatic nitrile and nitro group on human aortic smooth muscle cells via inhibition of cystathionine-γ-lyaseYajing Ji, Austin Bowersock, Alec R Badour, et al.
Science (New York, N.Y.)|July 30, 2005
A phenylalanine clamp catalyzes protein translocation through the anthrax toxin poreBryan A Krantz, Roman A Melnyk, Sen Zhang, et al.
Biochemistry|November 30, 2007
Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocationD Shyamali Wimalasena, John C Cramer, Blythe E Janowiak, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cellular Microbiology|April 16, 2002
Yersinia effectors target mammalian signalling pathwaysStephen J Juris, Feng Shao, Jack E Dixon
The Journal of General Physiology|February 11, 2009
Evidence for a proton-protein symport mechanism in the anthrax toxin channelDaniel Basilio, Stephen J Juris, R John Collier, et al.
FEBS Letters|December 21, 2005
Identification of otubain 1 as a novel substrate for the Yersinia protein kinase using chemical genetics and mass spectrometryStephen J Juris, Kavita Shah, Kevan Shokat, et al.
Infection and Immunity|July 20, 2007
Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxinStephen J Juris, Roman A Melnyk, Robert E Bolcome, et al.
The Journal of Biological Chemistry|March 27, 2004
Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigenDarran J Wigelsworth, Bryan A Krantz, Kenneth A Christensen, et al.
Biochimie|December 31, 2016
Dichotomous effects of isomeric secondary amines containing an aromatic nitrile and nitro group on human aortic smooth muscle cells via inhibition of cystathionine-γ-lyaseYajing Ji, Austin Bowersock, Alec R Badour, et al.
Science (New York, N.Y.)|July 30, 2005
A phenylalanine clamp catalyzes protein translocation through the anthrax toxin poreBryan A Krantz, Roman A Melnyk, Sen Zhang, et al.
Biochemistry|November 30, 2007
Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocationD Shyamali Wimalasena, John C Cramer, Blythe E Janowiak, et al.
Pageof 1